WAT

Waters Corporation

Price

$456.56

return (12m)

29.80%

p/e

265.23

p/bv

2.90

DIVIDEND YIELD

0.00%

WAT price

Waters

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment WAT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.45%

3 months

18.93%

1 year

29.80%

2 years

40.26%

5 years

26.41%

10 years

226.56%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals WAT

Valuation

P/E

265.23

Sector 0.88

Industry 3.36

P/BV

2.90

Sector 1.82

Industry 2.08

P/Revenue (PSR)

9.49

Sector 1.49

Industry 1.65

EV/EBITDA

Sector -45.42

Industry 1.46

EV/EBIT

Sector -48.36

Industry -4.97

P/EBITDA

49.19

Sector -30.89

Industry -49.47

P/EBIT

130.54

Sector -34.27

Industry -46.45

P/Total Assets

1.78

Sector 0.82

Industry 0.92

P/Net Current Assets

-8.66

Sector -23.91

Industry -9.30

P/Working Capital

21.33

Sector -3.81

Industry 2.66

EPS

1.69

Sector -0.70

Industry -0.60

BVPS

154.73

Sector 4.50

Industry 4.74

Efficiency

Gross Margin

50.78%

Sector 49.33%

Industry 50.68%

EBITDA Margin

13.07%

Sector -236.80%

Industry -51.91%

EBIT Margin

7.96%

Sector -19.73%

Industry -25.80%

Net Profit Margins

3.58%

Sector -23.90%

Industry -29.17%

Asset Turnover

0.07

Sector 0.13

Industry 0.15

Profitability

ROE

1.09%

Sector -24.31%

Industry -22.30%

ROA

0.67%

Sector -24.50%

Industry -24.15%

ROIC

Sector -514.78%

Industry -94.48%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.86

Sector 1.92

Industry 1.98

Net Debt / EBITDA

Sector -21.25

Industry -2.11

Net Debt / EBIT

Sector -17.49

Industry -1.59

Net Debt / Equity

Sector -0.99

Industry -0.29

Gross Debt / Equity

Sector -0.73

Industry -0.82

Equity/Assets

0.61

Sector 0.46

Industry 0.47

Liabilities/Assets

0.39

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

10.76%

Sector -

Industry -

5Y Earnings CAGR

-24.84%

Sector -

Industry -

Fundamentals WAT

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Waters ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$456.56

Fair Value

$76.70

Upside

-83.20%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
WAT Waters Corporation	$456.56	27.00%	0.00%	265.23	2.90	1.09%	3.58%
TMO Thermo Fisher Scientific Inc.	$678.78	18.97%	0.28%	34.94	4.52	12.94%	14.97%
DHR Danaher Corporation	$232.34	5.14%	0.64%	39.79	3.03	7.61%	15.95%
IQV IQVIA Holdings Inc.	$279.02	26.53%	0.00%	33.63	7.34	21.82%	8.10%
SHC Sotera Health Company	$18.38	8.99%	0.00%	31.47	7.73	24.56%	13.44%
CGEN Compugen Ltd.	$1.94	7.50%	0.00%	6.58	2.04	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
JNJ Johnson & Johnson	$266.02	43.64%	2.02%	39.76	7.85	19.74%	16.20%
LLY Eli Lilly and Compay	$1,282.23	56.32%	0.52%	42.82	33.76	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$453.13	-17.09%	0.00%	51.68	8.85	17.12%	28.39%
SNY Sanofi	$41.59	-16.30%	4.26%	3.88	0.72	18.43%	14.25%
NVS Novartis AG	$154.17	20.56%	2.06%	22.52	6.85	30.41%	23.29%
ABT Abbott Laboratories	$104.61	-15.11%	2.39%	32.43	0.00	-%	11.52%
MDT Medtronic PLC	$94.55	4.27%	2.98%	23.51	2.42	10.29%	13.93%
GSK GlaxoSmithKline PLC	$51.15	22.37%	3.51%	15.70	4.43	28.24%	14.54%
CVS CVS Health Corporation	$92.51	17.32%	2.86%	24.33	1.49	6.12%	1.18%
BSX Boston Scientific Corp.	$45.40	-55.10%	0.00%	18.43	2.71	14.73%	17.49%
TMDX TransMedics Group Inc.	$71.61	-45.13%	0.00%	16.39	4.80	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$569.61	-11.12%	0.00%	38.97	27.54	70.67%	25.03%
RMD ResMed Inc.	$253.07	-1.44%	0.96%	24.27	5.61	23.13%	26.94%
HCA HCA Healthcare Inc.	$467.51	5.08%	0.65%	15.24	-32.49	-213.15%	8.77%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

WAT - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Waters

Waters Corporation

Average Investor10 user rating

4.0 (6 people)

United States

68 years

Founded: 1958

1995

Time since IPO - 31 years

16.000

Employees

Waters Corporation (United States) is listed on the NYSE and has a market capitalization of $44.07 billion, with shareholders equity totaling $15.20 billion.

The company employs approximately 16.000 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Waters Corporation reported $4.64 billion in revenue, generating net income of $166.14 million.

Key financial metrics include a P/E ratio of 265.23, a price-to-book (P/B) ratio of 2.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker WAT.

Market cap

$44.07 billion

Net worth

$15.20 billion

$15,195,000,000.00

Assets

$24.75 billion

$24,751,000,000.00

Total Shares Outstanding

98.20 million

98,204,000

Average Daily Trading Volume

$1.10 million

$1,097,075.00

Sector

Health

Industry

Life Science Tools and Services

WAT

revenue by Business Segment Waters

Revenue by Region Waters

WAT revenue and profits

Financial Results WAT

DRAG THE FRAME TO SEE MORE DATA

WAT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$92.51 17,32% (12M)

P/E

24.33

2.86%

ROE

6.12%

P/BV

1.49

CI - Cigna

$306.21 3,76% (12M)

P/E

11.94

2.00%

ROE

16.04%

P/BV

1.92

CNC - Centene

$67.78 98,94% (12M)

P/E

-6.87

0.00%

ROE

-22.53%

P/BV

1.55

HUM - Humana

$419.80 46,83% (12M)

P/E

39.79

0.84%

ROE

6.63%

P/BV

2.64

SNY - Sanofi

$41.59 --16,30% (12M)

P/E

3.88

4.26%

ROE

18.43%

P/BV

0.72

JNJ - Johnson & Johnson

$266.02 43,64% (12M)

P/E

39.76

2.02%

ROE

19.74%

P/BV

7.85

LLY - Eli Lilly

$1,282.23 56,32% (12M)

P/E

42.82

0.52%

ROE

78.84%

P/BV

33.76

HCA - HCA Healthcare

$467.51 5,08% (12M)

P/E

15.24

0.65%

ROE

-213.15%

P/BV

-32.49